Risks of proton pump inhibitors for patients with cirrhosis: The controversy remains

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 66; no. 1; pp. 294 - 295
Main Authors de Mattos, Ângelo Zambam, Miozzo, Suelen Aparecida da Silva, Tovo, Cristiane Valle, de Mattos, Angelo Alves
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.07.2017
Subjects
Cirrhosis
Fibrosis
Hepatology
Humans
Liver Cirrhosis
Proton Pump Inhibitors
Risk
Online AccessGet full text
ISSN0270-9139
1527-3350
1527-3350
DOI10.1002/hep.29132

Cover

More Information
Bibliography:Potential conflict of interest: Nothing to report.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
ISSN:0270-9139
1527-3350
1527-3350
DOI:10.1002/hep.29132